Multinational randomised controlled clinical trial of etoricoxib in the treatment of rheumatoid arthritis

Completed

• Conditions: Rheumatoid arthritis; Musculoskeletal Diseases; Arthropathies

• Registration Number: ISRCTN25142273
• Lead Sponsor: Merck & Co Inc (USA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2002-05-09
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 891

Inclusion Criteria

1. Patients with rheumatoid arthritis
2. Aged greater than or equal to 18 years

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration